President
Dr. Dahlem Consulting, Llc
AeroLeads people directory · profile
Andrew M. Dahlem Email & Phone Number
President
at
Dr. Dahlem Consulting, LLC
3 work emails found
@lilly.com
4 phones found area 317 and 800
LinkedIn matched
✓ Verified July 2026
4 data sources
Profile completeness 100%
Current company
Role
President
Location
Indianapolis, Indiana, United States
Who is Andrew M. Dahlem? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Andrew M. Dahlem is listed as President at Dr. Dahlem Consulting, LLC, based in Indianapolis, Indiana, United States. AeroLeads shows a work email signal at lilly.com, phone signal with area code 317, 800, and a matched LinkedIn profile for Andrew M. Dahlem.
Andrew M. Dahlem previously worked as Board Member at Syra Health and Co-Founder and Advisor at Gate Neurosciences, Inc.. Andrew M. Dahlem holds Phd, Toxicology, Drug Metabolism from University Of Illinois Urbana-Champaign.
Company email context
Email format at Dr. Dahlem Consulting, LLC
This section adds company-level context without repeating Andrew M. Dahlem's masked contact details.
*@lilly.com
74% confidence
AeroLeads found 3 current-domain work email signals for Andrew M. Dahlem. Compare company email patterns before reaching out.
Profile bio
About Andrew M. Dahlem
Experienced Vice President Research and Development with a demonstrated history of success in the pharmaceutical industry. Strong scientific and operations professional skilled in Research and Development Strategy, Drug Development, Due Diligence, Portfolio Enablement, Competitive Intelligence, Clinical Trial Design, Toxicology, and Drug Metabolism. Excellent mentor and coach to key talent and strong team building skills. Strong history of success in leading and managing a portfolio of assets from Lead Declaration to Phase 2 clinical outcomes. Active in venture fund collaboration and in external innovation investment decisions.
Listed skills include Biotechnology, Pharmaceutical Industry, Biopharmaceuticals, Clinical Trials, and 46 others.
Current workplace
Andrew M. Dahlem's current company
Company context helps verify the profile and gives searchers a useful next step.
12 roles · 37 years
Andrew M. Dahlem work experience
A career timeline built from the work history available for this profile.
Board Member
Current
Oct 2023 - Present
Co-Founder And Advisor
CurrentActively engaged in acquisition and development of novel entities to meet patient needs in neurosciences.
Apr 2019 - Present
President
Current
Dr. Dahlem Consulting, Llc
May 2018 - Present
Chief, Division Of Clinical Pharmacology And Senior Research Professor Of Medicine
Advancing the science of Clinical Pharmacology and providing a home for world class research, world class researchers, and education in drug discovery and development in the largest School of Medicine in the United States at Indiana University.
Nov 2018 - May 2022
Vice President Of Research Operations And Coo Lilly Research Laboratories (Lrl) And Lrl Europe
Reports to President of Lilly Research Laboratories. Vice-chair of portfolio management committee responsible for scientific and technical review of portfolio through Phase 2. Co-chair of Medical Plans Review Committee. Responsible for due diligence assessment prior to in-licensing of assets and technology for Lilly. Lead group of scientists with direct accountability for compliance, out-sourcing, academic collaborations, capital investment planning, competitive analysis, business process improvement, six sigma, and global research management. Lead business process integration efforts for strategic acquisitions and divestitures. Responsible for strategy and operations of Lilly Research Laboratories in Europe. Scientific advisor for Lilly venture investment.
2007 - Jan 2018
Vice President Of Toxicology, Drug Dispositon, Pharmacokinetics And Lrl Europe
Senior leadership and oversight of the Toxicology and Drug Disposition Division. Recruited and hired scientists. Led discussion and scientific design of ADME studies for portfolio assets. Interfaced with senior research and development leadership to deliver Lilly's portfolio of innovation. Managed the global business and scientific support. Oversight of outsourcing pre-clinical studies to support development. Implemented a discovery support strategy in order to increase the technical probability of success of molecules in development. Leader of pre-clinical portfolio governance committee from Lead Phase to Phase 2.
Oct 2001 - 2007
Executive Director Of Toxicology And Drug Disposition Lilly Research Laboratories (Lrl) And Europe
Leader of scientific staff and strategic direction for Toxicology division. Led strategy and operational oversight of European research labs in England, Germany, Spain and Belgium.
1998 - Oct 2001
Director, Drug Disposition And Biochemical Toxcology
Division leader of ADME and pharmacokinetic group supporting Lilly research and development portfolio. Managed audited functions and reviewed regulatory submissions supporting label claims and new product approvals. Senior leader of Investigative Toxicology group responsible for understanding mechanisms of toxicity of compounds in development. Led a cross functional research and development team to redesign the project management support of teams prior transition to Phase 3 development.
1994 - 1998
~4 yrs
Head, Biochemical Toxicology
Leader of the Investigative Toxicology portion of the toxicology division.
1992 - 1994
~2 yrs
Senior Pharmacologist
Designed and conducted pre-clinical ADME studies on Alzheimer's research projects and principal ADME investigator for the candidate selection of Viracept, an HIV protease inhibitor which eventually benefitted patients. Worked on cross functional teams to deliver project goals.
1990 - 1992
~2 yrs
Senior Research Chemist
Clinical Drug Metabolism. Designed studies. Interpreted data. Created assays for clinical drug metabolism, distribution, absorption and elimination studies. Worked as drug metabolism representative to clinical development teams. Led a group of Research Scientists in comparative biotransformation studies.
May 1989 - Oct 1990
2 education records
Andrew M. Dahlem education
Phd, Toxicology, Drug Metabolism
University Of Illinois Urbana-Champaign
Bs, Biology
The Ohio State University
FAQ
Frequently asked questions about Andrew M. Dahlem
Quick answers generated from the profile data available on this page.
What company does Andrew M. Dahlem work for?
Andrew M. Dahlem works for Dr. Dahlem Consulting, LLC.
What is Andrew M. Dahlem's role at Dr. Dahlem Consulting, LLC?
Andrew M. Dahlem is listed as President at Dr. Dahlem Consulting, LLC.
What is Andrew M. Dahlem's email address?
AeroLeads has found 3 work email signals at @lilly.com for Andrew M. Dahlem at Dr. Dahlem Consulting, LLC.
What is Andrew M. Dahlem's phone number?
AeroLeads has found 4 phone signal(s) with area code 317, 800 for Andrew M. Dahlem at Dr. Dahlem Consulting, LLC.
Where is Andrew M. Dahlem based?
Andrew M. Dahlem is based in Indianapolis, Indiana, United States while working with Dr. Dahlem Consulting, LLC.
What companies has Andrew M. Dahlem worked for?
Andrew M. Dahlem has worked for Dr. Dahlem Consulting, Llc, Syra Health, Gate Neurosciences, Inc., Indiana University School Of Medicine, and Eli Lilly And Company.
How can I contact Andrew M. Dahlem?
You can use AeroLeads to view verified contact signals for Andrew M. Dahlem at Dr. Dahlem Consulting, LLC, including work email, phone, and LinkedIn data when available.
What schools did Andrew M. Dahlem attend?
Andrew M. Dahlem holds Phd, Toxicology, Drug Metabolism from University Of Illinois Urbana-Champaign.
What skills is Andrew M. Dahlem known for?
Andrew M. Dahlem is listed with skills including Biotechnology, Pharmaceutical Industry, Biopharmaceuticals, Clinical Trials, Oncology, Life Sciences, Lifesciences, and Toxicology.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial